DECR2 p.Leu66Pro
c.197T>C · VCV4659293
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6661 | likely pathogenic |
|---|---|---|
| REVEL | 0.033 | moderately benign-leaning |
| SaProt | LLR -11.07 | damaging |
| ⇒ AlphaMissense and SaProt call this damaging; REVEL does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.18 | GERP -2 |
| Regional constraint | o/e 1.14 | unconstrained · MANE · 9,611 bp · p 0.0038 · regional, not allelic |
| Overall | ||
| CADD | 8.849 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00339% | 29,498 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,438 |
| African / African-American | 0.00133% | 74,920 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DECR2
- Protein
- p.Leu66Pro
- Coding
- c.197T>C
- MANE Select
- NM_020664
- Type
- single nucleotide variant
- Location
- chr16:406393 (GRCh38)
- Gene constraint
- LOEUF 1.731 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 95.77 · 2 PDB
- Residue 66
- an α-helix
Similar variants
- DECR2 p.Ala124Thr Uncertain significance ★ ⚠ same type
- DECR2 p.Ala129Thr Uncertain significance ★ ⚠ same type
- DECR2 p.Ala16Val Uncertain significance ★ ⚠ same type
- DECR2 p.Ala178Val Uncertain significance ★ ⚠ same type
- DECR2 p.Ala187Val Uncertain significance ★ ⚠ same type
- DECR2 p.Ala207Thr Uncertain significance ★ ⚠ same type
- DECR2 p.Ala246Thr Uncertain significance ★ ⚠ same type
- DECR2 p.Ala96Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/decr2-p-leu66pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown